다우존스 지수

무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

등록

IMUX

Immunic (IMUX)

Immunic Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:IMUX

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/08	20:20	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:IMUX	Immunic Inc
2024/05/08	19:45	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IMUX	Immunic Inc
2024/05/08	19:30	PR Newswire (US)	Immunic, Inc. Reports First Quarter 2024 Financial Results and Provides Corporate Update	NASDAQ:IMUX	Immunic Inc
2024/05/06	19:30	PR Newswire (US)	Immunic to Participate in Investor and Scientific Conferences in May	NASDAQ:IMUX	Immunic Inc
2024/05/01	19:30	PR Newswire (US)	Immunic, Inc. to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate Update	NASDAQ:IMUX	Immunic Inc
2024/04/30	19:30	PR Newswire (US)	Immunic Announces Publication of Extended Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis in the Peer Reviewed Journal, Neurology® Neuroimmunology & Neuroinflammation	NASDAQ:IMUX	Immunic Inc
2024/04/04	19:30	PR Newswire (US)	Immunic to Host MS R&D Day and Participate in Investor Conferences in April	NASDAQ:IMUX	Immunic Inc
2024/03/20	19:30	PR Newswire (US)	Immunic Receives Notice of Allowance for Composition-of-Matter Patent of a Specific Polymorph of Vidofludimus Calcium in the United States	NASDAQ:IMUX	Immunic Inc
2024/03/09	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IMUX	Immunic Inc
2024/03/07	20:30	PR Newswire (US)	Immunic to Participate in Investor and Scientific Conferences in March	NASDAQ:IMUX	Immunic Inc
2024/03/07	11:52	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IMUX	Immunic Inc
2024/03/07	11:51	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IMUX	Immunic Inc
2024/03/07	11:51	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IMUX	Immunic Inc
2024/03/07	11:50	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IMUX	Immunic Inc
2024/03/07	11:50	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IMUX	Immunic Inc
2024/03/07	11:50	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IMUX	Immunic Inc
2024/02/29	20:30	PR Newswire (US)	Immunic Presents Data From Phase 2 CALLIPER and CALVID-1 Trials of Vidofludimus Calcium at the ACTRIMS Forum 2024	NASDAQ:IMUX	Immunic Inc
2024/02/22	20:38	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:IMUX	Immunic Inc
2024/02/22	20:35	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IMUX	Immunic Inc
2024/02/22	20:30	PR Newswire (US)	Immunic, Inc. Reports Year End 2023 Financial Results and Provides Corporate Update	NASDAQ:IMUX	Immunic Inc
2024/02/15	20:30	PR Newswire (US)	Immunic, Inc. to Announce Financial Results for the Year Ended December 31, 2023, and Provide Corporate Update	NASDAQ:IMUX	Immunic Inc
2024/02/15	06:05	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:IMUX	Immunic Inc
2024/02/14	22:47	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:IMUX	Immunic Inc
2024/02/14	21:55	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:IMUX	Immunic Inc
2024/02/14	06:36	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:IMUX	Immunic Inc
2024/02/05	22:30	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:IMUX	Immunic Inc
2024/02/01	20:30	PR Newswire (US)	Immunic to Participate in Investor and Scientific Conferences in February	NASDAQ:IMUX	Immunic Inc
2024/01/25	07:05	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:IMUX	Immunic Inc
2024/01/20	06:07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IMUX	Immunic Inc
2024/01/20	06:07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IMUX	Immunic Inc

검색 관련기사 보기:NASDAQ:IMUX

1 2 3 4 5 6 7 8 9 10 다음 >>

Financial Select Sector

Energy Select Sector SPDR

Health Care Select Sector

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관